Examining aspirin interruption or continuation in patients with coronary stents undergoing non-cardiac surgery

Among patients undergoing non-cardiac surgery more than one year after coronary drug-eluting stent (DES) implantation, there was no difference with respect to ischemic outcomes or major bleeding between perioperative aspirin monotherapy and receiving no antiplatelet therapy, according to late-breaking research presented in a Hot Line session August 31 at ESC Congress 2024.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup